LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the company has filed a Citizen Petition with the Food and Drug Administration (FDA). Cubist has a unique understanding of daptomycin and is sharing this understanding with the FDA, via the Citizen Petition, in the interest of public health.
